Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Sales | 160 | 2,310 | 2,160 | 2,830 | 2,890 |
| Cost of Goods | 150 | 1,800 | 1,660 | 2,230 | 2,270 |
| Gross Profit | 10 | 510 | 500 | 600 | 620 |
| Operating Expenses | 580 | 1,331 | 1,269 | 1,082 | 938 |
| Operating Income | -420 | -21 | -109 | -252 | -48 |
| Interest Expense | 0 | 30 | 1 | 16 | 4 |
| Other Income | 210 | 11 | -260 | -852 | 42 |
| Pre-tax Income | -210 | -40 | -370 | -1,120 | -10 |
| Income Tax | 0 | 0 | 0 | -10 | 0 |
| Net Income Continuous | -210 | -40 | -370 | -1,110 | -10 |
| Net Income | $-210 | $-40 | $-370 | $-1,110 | $-10 |
| EBITDA(a) | $-400 | $-1 | $-49 | $-182 | $32 |